x
Filter:
Filters applied
- Coronavirus (COVID-19) Collection
- HIVRemove HIV filter
- Antiretroviral therapyRemove Antiretroviral therapy filter
- 2017 - 2022Remove 2017 - 2022 filter
Coronavirus (COVID-19) Collection
1 Results
- Research ArticleOpen Access
The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease—A report from Central and Eastern Europe
International Journal of Infectious DiseasesVol. 104p293–296Published online: December 14, 2020- Justyna D. Kowalska
- Kerstin Kase
- Anna Vassilenko
- Arjan Harxhi
- Botond Lakatos
- Gordana Dragović Lukić
- and others
Cited in Scopus: 15The on-going COVID-19 pandemic may affect many aspects of HIV care, from individual health to the continuation of antiretroviral treatment and its sustainability (Kowalska et al., 2020). It is currently assumed that there is no increased risk of infection, or of a more severe course of the COVID-19 disease among HIV-positive patients on combined antiretroviral therapy (cART) (Anon, 2021). This condition may not be well fulfilled in many Central and Eastern Europe (CEE) countries, where the cascade of care is insufficient and there are many barriers to accessing cART (Balayan et al., 2019).
